Array BioPharma (ARRY) Tops Q3 EPS by 4c
Tweet Send to a Friend
Array BioPharma Inc. (Nasdaq: ARRY) reports Q3 loss of $0.63 (ex-items), 4 cents better ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
